INmune Bio Inc (NAS:INMB)
$ 1.75 -0.030 (-1.69%) Market Cap: 46.52 Mil Enterprise Value: 26.68 Mil PE Ratio: 0 PB Ratio: 2.36 GF Score: 57/100

Q1 2026 INmune Bio Inc Earnings Call Transcript

May 7, 2026 / 08:30 PM GMT
Release Date Price: $1.43 (-5.92%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

INMB.OQ - INmune Bio Inc
Q1 2026 INmune Bio Inc Earnings Call
May 07, 2026 / 08:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Greetings, and welcome to the Immune Bio First Quarter 2025 Earnings Call.

At this time, all participants are in a listen-only mode. Later, you will have the opportunity to ask questions during the question-and-answer session.

You may register to ask a question at any time by pressing star 1 on your telephone keypad. You may withdraw yourself from the queue by pressing star 2.

As a reminder, this conference is being recorded. A transcript will follow within 24 hours of this conference call.

At this time, it is my pleasure to introduce Dr. Excuse me, Mr. David Ma, CFO of ImmuneBio. David.

--------------------------------------------------------------------------------
Unidentified_2 [2]
---
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot